Cancer Commentary, Cancer Treatments, Cancer News, Cancer Stories, Cancer Research.

June 21st, 2008

GSK Won UK Cervical Cancer Contract

GlaxoSmithKline has won a contract with the UK’s NHS to supply its cervical cancer vaccine,
Cervarix.
The battle to supply a vaccine against cervical cancer for use across Britain has been won by GlaxoSmithKline (GSK).
Cervarix, the GSK vaccine, will be given to girls aged between 12 and 13, starting in September this year, and should prevent […]

By Gloria Gamat -- 2 comments

September 25th, 2007

Cervical Cancer Vaccine To Undergo Evaluation

Speaking of cervical cancer vaccines, there are two notables: Gardasil by Merck which was approved by the FDA earlier this year and Cervarix by GlaxoSmithKline which is expected to be approved by the FDA later this year (but already approved in Australia).

Regarding these HPV vaccines that will protect women against cervical cancer, the CDC recommends […]

By Gloria Gamat -- 1 comment

June 29th, 2007

GSK’s Cervarix™: A New, Broader Cervical Cancer Vaccine

Cervarix™ is the cervical cancer vaccine candidate of GlaxoSmithKline which have been previously known to protect from human papillomavirus (HPV) types 16 and 18.
Now, an Australian study of under 150 Perth women included in a major international research at the Telethon Institute for Child Health Research proved that the new Cervarix vaccine provides broader protection […]

By Gloria Gamat -- 0 comments